The POSITIVE study, sponsored by the German Cancer Research Center, explores the impact of a 24-week exercise intervention program (EIP) on quality of life and immune function in patients with advanced NSCLC undergoing palliative treatment. With an enrollment target of 250 patients, the study aims to address a significant unmet need in supportive care for lung cancer patients, potentially enhancing patient outcomes and quality of life. The findings could position the sponsor favorably within the oncology supportive care market, which is increasingly recognizing the importance of non-pharmacological interventions. Given the rising incidence of lung cancer and the growing emphasis on holistic patient care, successful outcomes may lead to broader adoption of exercise programs in clinical practice, influencing competitive dynamics in the supportive care landscape.